Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

• Canaccord Genuity 43rd Annual Growth Conference: On Wednesday, August 9th, Ben Berry, Chief Financial Officer, will be meeting with investors at the conference which is scheduled to take place in Boston, MA.
• Baird 2023 Global Healthcare Conference: On Tuesday, September 12th, Ben Berry, Chief Financial Officer, and Brady Shirley, Chief Operating Officer, will be meeting with investors at the conference, which is scheduled to take place in New York, NY.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Contact:

Derek LeckowVice President, Investor RelationsEnovis Corporation+1-302-421-1971[email protected]

***

Source: Enovis Corporation

Source: Enovis Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Crypto News Today: AlphaPepe Presale Nears Sellout With 11,000 Buyers While XRP Price Prediction Eyes $10
• Investcorp Credit Management BDC, Inc. Announces Financial Results for the Quarter Ended June 30, 2026
• Reconnect, a Contender for Best Resort in Sulawesi, Plans 2027 Expansion